Last reviewed · How we verify
Morphine 10mg
At a glance
| Generic name | Morphine 10mg |
|---|---|
| Also known as | Morphine injection |
| Sponsor | Assiut University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
- 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain (PHASE2)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
- Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial (PHASE4)
- A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma (PHASE2)
- Multimodal Analgesia Strategies After Major Shoulder Ambulatory Surgery (PHASE4)
- CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS (PHASE4)
- Non-Narcotic Pain Control After ACL Reconstruction (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Morphine 10mg CI brief — competitive landscape report
- Morphine 10mg updates RSS · CI watch RSS
- Assiut University portfolio CI